Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

C. Amy Peterson


  • Evp, Chief Development Officer at Cytomx Therapeutics Inc. (CTMX), 2020-02-19
  • Cmo, Immuno-Oncology at Beigene Ltd. (BGNE), 2018-12-19
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BGNE $135.54 611 Officer 0 2018-12-18 Filing
BGNE $134.81 3,600 Officer 611 2018-12-18 Filing
BGNE $133.88 2,402 Officer 4,211 2018-12-18 Filing
BGNE $132.70 1,897 Officer 6,613 2018-12-18 Filing
BGNE $131.74 1,631 Officer 8,510 2018-12-18 Filing